| regulation of blood pressure | GO:0008217 | 93 | 0.361 | |
| regulation of cell activation | GO:0050865 | 289 | 0.356 | |
| regulation of secretion | GO:0051046 | 274 | 0.344 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.316 | |
| cytokine production | GO:0001816 | 319 | 0.278 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.277 | |
| ossification | GO:0001503 | 216 | 0.263 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.254 | |
| muscle system process | GO:0003012 | 141 | 0.250 | |
| cation homeostasis | GO:0055080 | 212 | 0.241 | |
| regulation of defense response | GO:0031347 | 233 | 0.224 | Human |
| cation transport | GO:0006812 | 399 | 0.219 | |
| regulation of macrophage activation | GO:0043030 | 17 | 0.210 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.210 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.206 | |
| immune effector process | GO:0002252 | 321 | 0.206 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.201 | |
| muscle contraction | GO:0006936 | 101 | 0.200 | |
| activation of immune response | GO:0002253 | 138 | 0.193 | Human |
| nitrogen compound transport | GO:0071705 | 271 | 0.187 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.186 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.177 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.177 | |
| heart morphogenesis | GO:0003007 | 178 | 0.175 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.174 | |
| muscle cell development | GO:0055001 | 133 | 0.173 | |
| angiogenesis | GO:0001525 | 201 | 0.161 | |
| locomotory behavior | GO:0007626 | 195 | 0.147 | |
| tissue homeostasis | GO:0001894 | 115 | 0.147 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.141 | |
| amide transport | GO:0042886 | 138 | 0.140 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.136 | |
| blood circulation | GO:0008015 | 195 | 0.136 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.134 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.130 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.128 | |
| synaptic transmission | GO:0007268 | 329 | 0.125 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.122 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.119 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.118 | |
| oxidation reduction process | GO:0055114 | 342 | 0.115 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.115 | |
| transmembrane transport | GO:0055085 | 412 | 0.114 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.113 | |
| lung development | GO:0030324 | 164 | 0.108 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.108 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.107 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.107 | |
| cardiac cell development | GO:0055006 | 41 | 0.107 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.105 | |
| hormone metabolic process | GO:0042445 | 86 | 0.103 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.103 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.102 | Human |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.099 | |
| regulation of system process | GO:0044057 | 200 | 0.099 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.099 | |
| regulation of ossification | GO:0030278 | 112 | 0.098 | |
| muscle fiber development | GO:0048747 | 76 | 0.095 | |
| protein localization to membrane | GO:0072657 | 108 | 0.091 | |
| cellular response to lipid | GO:0071396 | 145 | 0.090 | |
| tissue remodeling | GO:0048771 | 102 | 0.089 | |
| kidney epithelium development | GO:0072073 | 121 | 0.089 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.089 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.087 | |
| exocytosis | GO:0006887 | 121 | 0.086 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.086 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.085 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.085 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.083 | |
| striated muscle cell development | GO:0055002 | 125 | 0.083 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.083 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.083 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.083 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.080 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.079 | |
| blastocyst development | GO:0001824 | 80 | 0.079 | |
| respiratory tube development | GO:0030323 | 167 | 0.078 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.078 | |
| heart contraction | GO:0060047 | 93 | 0.077 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.077 | |
| midgut development | GO:0007494 | 4 | 0.076 | |
| muscle tissue development | GO:0060537 | 308 | 0.076 | |
| heart process | GO:0003015 | 94 | 0.076 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.076 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.076 | |
| telencephalon development | GO:0021537 | 186 | 0.076 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.075 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.075 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.075 | |
| regulation of cell motility | GO:2000145 | 236 | 0.075 | |
| t cell activation | GO:0042110 | 289 | 0.073 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.073 | |
| bone mineralization | GO:0030282 | 54 | 0.073 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.072 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.071 | |
| amine metabolic process | GO:0009308 | 45 | 0.071 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.070 | |
| response to inorganic substance | GO:0010035 | 96 | 0.070 | |
| peptide transport | GO:0015833 | 133 | 0.069 | |
| renal vesicle induction | GO:0072034 | 3 | 0.068 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.068 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.067 | |
| sensory perception | GO:0007600 | 245 | 0.066 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.066 | Human |
| protein secretion | GO:0009306 | 111 | 0.066 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.066 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.065 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.065 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.065 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.064 | |
| response to nutrient levels | GO:0031667 | 109 | 0.064 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.064 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.063 | |
| insulin secretion | GO:0030073 | 89 | 0.063 | |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | GO:0061179 | 4 | 0.062 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.061 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.060 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.060 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.060 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.060 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.060 | |
| inflammatory response | GO:0006954 | 244 | 0.060 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.059 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.059 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.059 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.058 | |
| response to testosterone | GO:0033574 | 3 | 0.058 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.058 | Human |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.058 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.058 | |
| negative regulation of growth | GO:0045926 | 99 | 0.057 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.057 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.057 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.057 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.056 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.056 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.055 | |
| action potential | GO:0001508 | 78 | 0.055 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.054 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.054 | |
| skeletal system development | GO:0001501 | 356 | 0.054 | |
| sodium ion transport | GO:0006814 | 73 | 0.054 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.054 | |
| negative regulation of peptide hormone secretion | GO:0090278 | 16 | 0.054 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.053 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.052 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.052 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.052 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.052 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.052 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.052 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.052 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.051 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.051 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.050 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.050 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.050 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.050 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.049 | |
| calcium ion transport | GO:0006816 | 159 | 0.049 | |
| endocytosis | GO:0006897 | 168 | 0.049 | |
| spemann organizer formation | GO:0060061 | 2 | 0.049 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.048 | |
| adult behavior | GO:0030534 | 135 | 0.048 | |
| urogenital system development | GO:0001655 | 261 | 0.048 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.047 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.047 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.047 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.047 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.046 | |
| regulation of wound healing | GO:0061041 | 40 | 0.046 | |
| forebrain development | GO:0030900 | 302 | 0.046 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.046 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.046 | |
| macrophage activation | GO:0042116 | 27 | 0.045 | |
| myotube differentiation | GO:0014902 | 105 | 0.045 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.045 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.045 | |
| response to oxidative stress | GO:0006979 | 123 | 0.044 | |
| innate immune response | GO:0045087 | 157 | 0.044 | Human |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.044 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.043 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.043 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.043 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.043 | |
| response to acid chemical | GO:0001101 | 111 | 0.043 | |
| protein maturation | GO:0051604 | 176 | 0.043 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.043 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.042 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.042 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.042 | |
| maintenance of location | GO:0051235 | 89 | 0.042 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.042 | |
| cellular homeostasis | GO:0019725 | 240 | 0.042 | |
| regulation of protein localization | GO:0032880 | 231 | 0.042 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.042 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.042 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.042 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.041 | |
| organelle assembly | GO:0070925 | 177 | 0.041 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.041 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.040 | |
| stem cell development | GO:0048864 | 219 | 0.040 | |
| organic acid transport | GO:0015849 | 101 | 0.040 | |
| striated muscle contraction | GO:0006941 | 45 | 0.040 | |
| regulation of antigen receptor mediated signaling pathway | GO:0050854 | 29 | 0.040 | |
| regulation of tube size | GO:0035150 | 57 | 0.040 | |
| renal system process | GO:0003014 | 48 | 0.040 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.040 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.039 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.039 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.039 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.039 | |
| organ growth | GO:0035265 | 117 | 0.039 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.039 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.039 | |
| regulation of protein processing | GO:0070613 | 96 | 0.039 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.039 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.039 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.039 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.038 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.038 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.038 | |
| axonogenesis | GO:0007409 | 274 | 0.038 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.038 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.038 | |
| t cell differentiation | GO:0030217 | 174 | 0.038 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.038 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.037 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.037 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.037 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.037 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.037 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.037 | |
| monoamine transport | GO:0015844 | 33 | 0.036 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.036 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.036 | |
| endomembrane system organization | GO:0010256 | 147 | 0.036 | |
| regulation of cell migration | GO:0030334 | 219 | 0.036 | |
| peptide secretion | GO:0002790 | 114 | 0.036 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.036 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.036 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.036 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.036 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.036 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.036 | |
| nephron development | GO:0072006 | 109 | 0.036 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.036 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.035 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.035 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.035 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.035 | |
| regulation of ion transport | GO:0043269 | 215 | 0.035 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.035 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.035 | |
| bone remodeling | GO:0046849 | 53 | 0.035 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.035 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.035 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.035 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.035 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.035 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.035 | |
| germ cell development | GO:0007281 | 185 | 0.034 | |
| biomineral tissue development | GO:0031214 | 64 | 0.034 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.034 | |
| skin development | GO:0043588 | 220 | 0.034 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.034 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.034 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.034 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.034 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.034 | Human |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.034 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.034 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.034 | |
| polyol metabolic process | GO:0019751 | 26 | 0.034 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.034 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.033 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.033 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.033 | |
| tissue migration | GO:0090130 | 68 | 0.033 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.033 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.033 | |
| circulatory system process | GO:0003013 | 197 | 0.033 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.033 | |
| mitochondrion organization | GO:0007005 | 134 | 0.032 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.032 | |
| connective tissue development | GO:0061448 | 179 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.032 | |
| pallium development | GO:0021543 | 120 | 0.032 | |
| leukocyte migration | GO:0050900 | 124 | 0.032 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.032 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.032 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.032 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.032 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.032 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.032 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.032 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.032 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.031 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.031 | |
| positive regulation of camp biosynthetic process | GO:0030819 | 19 | 0.031 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.031 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.031 | |
| kidney development | GO:0001822 | 213 | 0.031 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.031 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.031 | |
| dna metabolic process | GO:0006259 | 303 | 0.031 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.031 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.031 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.031 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.031 | |
| cerebral cortex development | GO:0021987 | 86 | 0.031 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.031 | |
| respiratory system development | GO:0060541 | 190 | 0.031 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.030 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.030 | |
| cardiac chamber development | GO:0003205 | 108 | 0.030 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.030 | |
| ear morphogenesis | GO:0042471 | 118 | 0.030 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.030 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.030 | |
| acid secretion | GO:0046717 | 33 | 0.030 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.030 | |
| positive regulation of growth | GO:0045927 | 104 | 0.030 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.029 | |
| olfactory learning | GO:0008355 | 2 | 0.029 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.029 | |
| nephric duct formation | GO:0072179 | 4 | 0.029 | |
| regulation of cell size | GO:0008361 | 72 | 0.029 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.029 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.029 | |
| myotube cell development | GO:0014904 | 60 | 0.029 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.029 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.029 | |
| regulation of anagen | GO:0051884 | 1 | 0.029 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.029 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.029 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.029 | |
| septum primum development | GO:0003284 | 4 | 0.029 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.029 | |
| cell recognition | GO:0008037 | 83 | 0.029 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.029 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.029 | |
| response to oxygen levels | GO:0070482 | 62 | 0.028 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.028 | |
| gland development | GO:0048732 | 330 | 0.028 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.028 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.028 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.028 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.028 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.028 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.028 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.028 | |
| membrane organization | GO:0061024 | 245 | 0.028 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.028 | Human |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.028 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.028 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.028 | |
| cytokine secretion | GO:0050663 | 72 | 0.028 | |
| metanephric tubule development | GO:0072170 | 18 | 0.028 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.028 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.028 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.027 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.027 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.027 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.027 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.027 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.027 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.027 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.027 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.027 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.027 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.027 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.027 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.027 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.027 | |
| defense response to other organism | GO:0098542 | 197 | 0.027 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.026 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.026 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.026 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.026 | |
| regulation of heart growth | GO:0060420 | 31 | 0.026 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.026 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.026 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.026 | |
| myeloid cell activation involved in immune response | GO:0002275 | 34 | 0.026 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.026 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.026 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.026 | |
| maintenance of cell number | GO:0098727 | 3 | 0.026 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.025 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.025 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.025 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.025 | |
| axon guidance | GO:0007411 | 141 | 0.025 | |
| peptide metabolic process | GO:0006518 | 46 | 0.025 | |
| developmental maturation | GO:0021700 | 193 | 0.025 | |
| renal inner medulla development | GO:0072053 | 3 | 0.025 | |
| hormone secretion | GO:0046879 | 128 | 0.025 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.025 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.025 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.025 | |
| cell adhesion | GO:0007155 | 329 | 0.025 | |
| adaptive immune response | GO:0002250 | 155 | 0.025 | |
| fat cell differentiation | GO:0045444 | 160 | 0.025 | |
| negative regulation of mast cell degranulation | GO:0043305 | 4 | 0.025 | |
| glucose homeostasis | GO:0042593 | 128 | 0.025 | |
| membrane depolarization | GO:0051899 | 64 | 0.025 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.025 | |
| norepinephrine transport | GO:0015874 | 2 | 0.024 | |
| extracellular structure organization | GO:0043062 | 148 | 0.024 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.024 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.024 | |
| protein processing | GO:0016485 | 163 | 0.024 | |
| cognition | GO:0050890 | 149 | 0.024 | |
| digestive system development | GO:0055123 | 200 | 0.024 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.024 | |
| negative regulation of bone trabecula formation | GO:1900155 | 1 | 0.024 | |
| bundle of his development | GO:0003166 | 4 | 0.024 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.024 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.024 | |
| organelle fission | GO:0048285 | 170 | 0.024 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.024 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.024 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 70 | 0.024 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.024 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.024 | |
| regulation of resting membrane potential | GO:0060075 | 3 | 0.024 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.024 | |
| steroid metabolic process | GO:0008202 | 119 | 0.023 | |
| spermatogenesis | GO:0007283 | 284 | 0.023 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.023 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.023 | |
| foramen ovale closure | GO:0035922 | 1 | 0.023 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.023 | |
| nephron epithelium development | GO:0072009 | 92 | 0.023 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.023 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.023 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.023 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.023 | |
| response to growth factor | GO:0070848 | 198 | 0.023 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.023 | Human |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.023 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.023 | |
| mesonephros development | GO:0001823 | 97 | 0.023 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.023 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.023 | |
| nephron tubule development | GO:0072080 | 84 | 0.023 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.023 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.023 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.023 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.023 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.023 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.022 | |
| stem cell differentiation | GO:0048863 | 268 | 0.022 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.022 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.022 | |
| regulation of organ growth | GO:0046620 | 61 | 0.022 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.022 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.022 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.022 | |
| sa node cell action potential | GO:0086015 | 4 | 0.022 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.022 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.022 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.022 | |
| neuronal action potential | GO:0019228 | 54 | 0.022 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.022 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.022 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.022 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.022 | |
| negative regulation of mast cell activation | GO:0033004 | 6 | 0.022 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.022 | |
| sensory perception of sound | GO:0007605 | 97 | 0.021 | |
| temperature homeostasis | GO:0001659 | 26 | 0.021 | |
| positive regulation of smoothened signaling pathway | GO:0045880 | 23 | 0.021 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.021 | |
| myeloid leukocyte mediated immunity | GO:0002444 | 42 | 0.021 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.021 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.021 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.021 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.021 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.021 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.021 | |
| myelination | GO:0042552 | 74 | 0.021 | |
| response to starvation | GO:0042594 | 65 | 0.021 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.021 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.021 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.021 | |
| response to monosaccharide | GO:0034284 | 67 | 0.021 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.021 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.021 | |
